Showing 14,081 - 14,100 results of 46,043 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( 5 ((step decrease) OR (mean decrease)) ))', query time: 0.80s Refine Results
  1. 14081

    DataSheet1_Characterization of the PM2.5 aerosol fraction monitored at a suburban site in south-eastern Italy by integrating isotopic techniques and ion beam analysis.docx by Salvatore Romano (683443)

    Published 2022
    “…Using the isotopic markers of carbon and nitrogen by means of the IRMS, we determined values of δ<sup>15</sup>N between 4.5 and 10.6‰, which are consistent with the origin of PM2.5 from anthropic combustion processes and a secondary contribution from vehicular traffic. …”
  2. 14082
  3. 14083

    Conformational changes measured by fluorescence correlation spectrometry (FCS). by Sabina Eigenbrod (187226)

    Published 2017
    “…Addition of metal ions like copper (Cu<sup>2+</sup>) and manganese (Mn<sup>2+</sup>) as well as depletion of divalent metal ions with EDTA in the presence of 0.02% SDS had a much stronger impact on the aggregation of wt-rPrP than on TetraH>G-rPrP and H95G-rPrP. Data are shown as mean values of last five meanders ± SEM of four to six independent experiments with four replicates each.…”
  4. 14084

    Data information. by Zhenyu Yu (13893585)

    Published 2023
    “…The results show that (1) the average growth rate (GR) of SARS-CoV-2 in each province is logarithmically distributed with a mean value of 5.15%. …”
  5. 14085

    Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  6. 14086

    Image_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  7. 14087

    Image_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  8. 14088

    Table_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  9. 14089

    Table_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx by Majd Jawad (12157533)

    Published 2022
    “…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
  10. 14090

    The role of AGEs in high glucose-induced voltage-gated K<sup>+</sup> (K<sub>v</sub>) channels dysfunction in vascular smooth muscle cells (VSMCs). by Wen Su (332346)

    Published 2015
    “…K<sup>+</sup> currents were generated by 10-mV incremental depolarizing steps from -60 to +60 mV. …”
  11. 14091

    Table_2_α-Ketoglutarate stimulates cell growth through the improvement of glucose and glutamine metabolism in C2C12 cell culture.DOCX by Bingquan Yang (6389006)

    Published 2023
    “…</p>Results<p>The control cells showed a CFE at 50%, a typical cell growth curve in the first 5 days with a mean SGR at 0.86/day, and a mean cell count doubling time at 19.4 h. …”
  12. 14092

    Table_6_α-Ketoglutarate stimulates cell growth through the improvement of glucose and glutamine metabolism in C2C12 cell culture.DOCX by Bingquan Yang (6389006)

    Published 2023
    “…</p>Results<p>The control cells showed a CFE at 50%, a typical cell growth curve in the first 5 days with a mean SGR at 0.86/day, and a mean cell count doubling time at 19.4 h. …”
  13. 14093

    Table_3_α-Ketoglutarate stimulates cell growth through the improvement of glucose and glutamine metabolism in C2C12 cell culture.DOCX by Bingquan Yang (6389006)

    Published 2023
    “…</p>Results<p>The control cells showed a CFE at 50%, a typical cell growth curve in the first 5 days with a mean SGR at 0.86/day, and a mean cell count doubling time at 19.4 h. …”
  14. 14094

    Table_8_α-Ketoglutarate stimulates cell growth through the improvement of glucose and glutamine metabolism in C2C12 cell culture.DOCX by Bingquan Yang (6389006)

    Published 2023
    “…</p>Results<p>The control cells showed a CFE at 50%, a typical cell growth curve in the first 5 days with a mean SGR at 0.86/day, and a mean cell count doubling time at 19.4 h. …”
  15. 14095

    Table_7_α-Ketoglutarate stimulates cell growth through the improvement of glucose and glutamine metabolism in C2C12 cell culture.DOCX by Bingquan Yang (6389006)

    Published 2023
    “…</p>Results<p>The control cells showed a CFE at 50%, a typical cell growth curve in the first 5 days with a mean SGR at 0.86/day, and a mean cell count doubling time at 19.4 h. …”
  16. 14096

    Table_4_α-Ketoglutarate stimulates cell growth through the improvement of glucose and glutamine metabolism in C2C12 cell culture.DOCX by Bingquan Yang (6389006)

    Published 2023
    “…</p>Results<p>The control cells showed a CFE at 50%, a typical cell growth curve in the first 5 days with a mean SGR at 0.86/day, and a mean cell count doubling time at 19.4 h. …”
  17. 14097

    Table_9_α-Ketoglutarate stimulates cell growth through the improvement of glucose and glutamine metabolism in C2C12 cell culture.DOCX by Bingquan Yang (6389006)

    Published 2023
    “…</p>Results<p>The control cells showed a CFE at 50%, a typical cell growth curve in the first 5 days with a mean SGR at 0.86/day, and a mean cell count doubling time at 19.4 h. …”
  18. 14098

    Table_1_α-Ketoglutarate stimulates cell growth through the improvement of glucose and glutamine metabolism in C2C12 cell culture.DOCX by Bingquan Yang (6389006)

    Published 2023
    “…</p>Results<p>The control cells showed a CFE at 50%, a typical cell growth curve in the first 5 days with a mean SGR at 0.86/day, and a mean cell count doubling time at 19.4 h. …”
  19. 14099

    Data_Sheet_5_Personalized surgical planning for coronary bypass graft configurations using patient-specific computational modeling to avoid flow competition in arterial grafts.XLSX by Krish Chaudhuri (13866956)

    Published 2023
    “…The use of the computational models led to a significant decrease in the selection of unsatisfactory grafting configurations when surgeons employed “anaortic” (21.25% (17/80) vs. 1.25% (1/80), P < 0.001) but not “aortic” techniques (5% (4/80) vs. 0% (0/80), P = 0.64). …”
  20. 14100

    Data_Sheet_5_Personalized surgical planning for coronary bypass graft configurations using patient-specific computational modeling to avoid flow competition in arterial grafts.XLSX by Krish Chaudhuri (13866956)

    Published 2023
    “…The use of the computational models led to a significant decrease in the selection of unsatisfactory grafting configurations when surgeons employed “anaortic” (21.25% (17/80) vs. 1.25% (1/80), P < 0.001) but not “aortic” techniques (5% (4/80) vs. 0% (0/80), P = 0.64). …”